Lilly farms out R&D to Covance in $1.6 billion deal
This article was originally published in Scrip
Executive Summary
Lillyis to transform its research and development strategy after agreeing a $1.6 billion lab services contract with Covance. The CRO will buy Lilly's early drug development campus in Greenfield, Indiana, for $50 million as part of the deal, with 260 employees joining Covance.